Diphenhydramine

CHEMBL657 Phase 4 अनुमोदित Small molecule
Half-Life
2-8 hours
Bioavailability
Protein Binding
Molecular Weight
255.4 g/mol
LogP
3.3
Phase
4

Diphenhydramine is a first-generation antihistamine that blocks the H1 histamine receptor to relieve allergic reactions, hay fever, hives, and itching. Because the molecule readily crosses the blood-brain barrier, it also produces pronounced drowsiness, which is why it doubles as a short-term sleep aid, and its antiemetic action helps with motion sickness and nausea. A small molecule (C17H21NO), it carries anticholinergic activity that causes dry mouth, urinary retention, and similar effects, and its half-life of about 2 to 8 hours limits each dose's duration. These central and anticholinergic properties make it less suitable for regular long-term use than newer, non-sedating antihistamines. Diphenhydramine is an approved medicine sold widely over the counter for allergy and sleep indications.

A first-generation antihistamine widely used for allergic reactions, hay fever, hives, itching, and as a short-term sleep aid. It also has antiemetic properties used for motion sickness and nausea. Because it crosses the blood-brain barrier, it causes significant drowsiness and has anticholinergic side effects such as dry mouth and urinary retention, making it unsuitable for regular, long-term use.

आणविक भार

255.3550 g/mol

LogP

3.30

TPSA

12.50 Ų

लिपिंस्की RO5

उत्तीर्ण

चिकित्सीय क्षेत्र

अग्नाशय कैंसर अनिद्रा अल्ज़ाइमर रोग अस्थमा इंफ्लेमेटरी बाउल डिज़ीज़ उच्च रक्तचाप एटोपिक डर्मेटाइटिस (एक्जिमा) एट्रियल फ़िब्रिलेशन एंडोमेट्रियोसिस ऑन्कोलॉजी ओवेरियन कैंसर कोलोरेक्टल कैंसर क्रॉनिक ऑब्सट्रक्टिव पल्मोनरी डिज़ीज़ (COPD) क्रॉनिक किडनी डिज़ीज़ गाउट (गठिया) गैस्ट्रोइसोफेजियल रिफ्लक्स रोग जनरलाइज़्ड एंग्ज़ाइटी डिसऑर्डर टाइप 2 मधुमेह थायरॉइड कैंसर दर्द प्रबंधन दीर्घकालिक दर्द नॉन-अल्कोहलिक फैटी लिवर डिज़ीज़ नॉन-स्मॉल सेल लंग कैंसर पार्किंसन रोग प्रोस्टेट कैंसर बाइपोलर डिसऑर्डर मलेरिया मल्टीपल स्क्लेरोसिस माइग्रेन मूत्राशय कैंसर मेजर डिप्रेसिव डिसऑर्डर मेलानोमा मोटापा रुमेटॉइड आर्थराइटिस लिम्फोमा ल्यूकेमिया श्वसन रोग संक्रामक रोग सिज़ोफ्रेनिया सिस्टेमिक ल्यूपस एरिथेमेटोसस स्ट्रोक स्तन कैंसर हाइपरलिपिडेमिया हृदय विफलता हृदय-संवहनी रोग हेपेटाइटिस C

दवा वर्ग

क्रिया का तंत्र

First-generation H1 antihistamine with anticholinergic properties.

Pharmacokinetics (PK)

Half-Life 2-8 hours

Pharmacodynamics (PD)

तंत्र

First-generation H1 antihistamine with anticholinergic properties.

2D संरचना

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

CN(C)CCOC(c1ccccc1)c1ccccc1

InChI

InChI=1S/C17H21NO/c1-18(2)13-14-19-17(15-9-5-3-6-10-15)16-11-7-4-8-12-16/h3-12,17H,13-14H2,1-2H3

Molecular Formula

C17H21NO

HBD / HBA

- / 2

घूर्णनीय बंधन

6

भारी परमाणु

19

No side effects recorded

Side effect data is not yet available for this drug.

अक्सर पूछे जाने वाले प्रश्न

A first-generation antihistamine widely used for allergic reactions, hay fever, hives, itching, and as a short-term sleep aid. It also has antiemetic properties used for motion sickness and nausea. Because it crosses the blood-brain barrier, it causes significant drowsiness and has anticholinergic side effects such as dry mouth and urinary retention, making it unsuitable for regular, long-term use.

First-generation H1 antihistamine with anticholinergic properties.

Key pharmacokinetic parameters for Diphenhydramine: Half-life: 2-8 hours.

Yes, Diphenhydramine is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

Related Drugs

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL657. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 3100. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

चिकित्सा अस्वीकरण

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.